Literature DB >> 20945096

Lung diffusion capacity in early cirrhosis: is lung diffusion capacity a predictor of esophageal varices and ascites?

Jun Young Jung1, Dae Won Jun, Jae Hyung Lee.   

Abstract

BACKGROUND: Varices and ascites are clinical manifestations of hyperdynamic circulation syndrome originating from increased nitric oxide in cirrhosis. Research was conducted in order to find any correlation between lung diffusion capacity and the presence of varices and ascites in cirrhosis.
METHODS: The study was conducted on a total of 120 subjects. Tests for pulmonary function, including carbon monoxide diffusing capacity (DLCO) and fractional exhaled nitric oxide (FENO), were performed.
RESULTS: DLCO/alveolar ventilation (VA) values were lower in cirrhosis and chronic liver disease groups than in the control group (3.79 vs. 4.5 vs. 5.1 ml/mmHg/min, p<0.001). DLCO/VA showed a negative correlation with the Child score and the MELD score (r=-0.3 vs. r=-0.41). In patients with varices, the DLCO/VA value was 3.75 ml/mmHg/min, which was lower than the 4.12 ml/mmHg/min observed in patients without varices (p=0.029). FENO levels were higher in the chronic liver disease and liver cirrhosis groups than in the control group. FENO and DLCO showed a negative correlation (r=-0.25, p=0.006). The frequency of significant varix and decompensation were higher in the high FeNO group.
CONCLUSIONS: Lung diffusion capacity decreased according to the disease's severity in early cirrhosis, and showed a good correlation with esophageal varices and ascites.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20945096     DOI: 10.1007/s10620-010-1406-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

Review 1.  Pulmonary dysfunction in chronic liver disease.

Authors:  M B Fallon; G A Abrams
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

2.  Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2005-07       Impact factor: 25.083

3.  Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters.

Authors:  A Malinovschi; C Janson; T Holmkvist; D Norbäck; P Meriläinen; M Högman
Journal:  Eur Respir J       Date:  2006-04-26       Impact factor: 16.671

Review 4.  Hepatopulmonary syndrome.

Authors:  Miguel R Arguedas; Michael B Fallon
Journal:  Clin Liver Dis       Date:  2005-11       Impact factor: 6.126

5.  Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins.

Authors:  S Battista; F Bar; G Mengozzi; E Zanon; M Grosso; G Molino
Journal:  J Hepatol       Date:  1997-01       Impact factor: 25.083

Review 6.  The hyperdynamic circulation in cirrhosis: an overview.

Authors:  L Blendis; F Wong
Journal:  Pharmacol Ther       Date:  2001-03       Impact factor: 12.310

7.  Nitric oxide and carbon monoxide lung transfer in patients with advanced liver cirrhosis.

Authors:  Bruno Degano; Marie Mittaine; Hervé Guénard; Jacques Rami; Gilles Garcia; Nassim Kamar; Christophe Bureau; Jean-Marie Péron; Lionel Rostaing; Daniel Rivière
Journal:  J Appl Physiol (1985)       Date:  2009-05-07

8.  Pulmonary dysfunction in advanced liver disease: frequent occurrence of an abnormal diffusing capacity.

Authors:  J M Hourani; P E Bellamy; D P Tashkin; P Batra; M S Simmons
Journal:  Am J Med       Date:  1991-06       Impact factor: 4.965

9.  Prevalence of intrapulmonary vascular dilatations in normoxaemic patients with early liver cirrhosis.

Authors:  K P Mimidis; C Karatza; K V Spiropoulos; T Toulgaridis; N A Charokopos; K C Thomopoulos; V G Margaritis; V N Nikolopoulou
Journal:  Scand J Gastroenterol       Date:  1998-09       Impact factor: 2.423

10.  The relationship between severity of liver cirrhosis and pulmonary function tests.

Authors:  Irem Pembegul Yigit; Suleyman Savas Hacievliyagil; Yuksel Seckin; Ramazan Ilyas Oner; Melih Karincaoglu
Journal:  Dig Dis Sci       Date:  2007-12-13       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.